70710-1196Level 3
Rivastigmine (Rivastigmine)
**Product type:** Human Prescription Drug
**Active ingredient:** RIVASTIGMINE
**Strength:** 4.6 mg/24h
**Dosage form:** Patch, Extended Release
**Route:** Transdermal
**Labeler:** Zydus Pharmaceuticals USA Inc.
**Marketing category:** ANDA (ANDA206318)
**Pharmacologic class:** Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/70710-1196Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.